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The ability to map patterns of gene expression non-
invasively in living animals could have impact in
many areas of biology. Reporter systems compatible
with MRI could be particularly valuable, but existing
strategies tend to lack sensitivity or specificity.
Here we address the challenge of MRI-based gene
mapping using the reporter enzyme secreted alkaline
phosphatase (SEAP), in conjunction with a water-
soluble metalloporphyrin contrast agent. SEAP
cleaves the porphyrin into an insoluble product that
accumulates at sites of enzyme expression and can
be visualized by MRI and optical absorbance. The
contrast mechanism functions in vitro, in brain slices,
and in animals. The system also provides the possi-
bility of readout both in the living animal and
by postmortem histology, and it notably does not
require intracellular delivery of the contrast agent.
The solubility switch mechanism used to detect
SEAP could be adapted for imaging of additional
reporter enzymes or endogenous targets.
INTRODUCTION
MRIprovides exceptional ability to visualize soft tissue contrast at
submillimeter resolution in intact human and animal subjects.
AlthoughMRI offers powerful functionality for anatomical analysis
and functional studies based on blood flow, application ofMRI for
monitoring molecular level processes remains challenging due to
the relative insensitivity of MRI to molecular imaging probes
(Lelyveld et al., 2010). Canonical MRI contrast agents derived
from paramagnetic complexes that alter longitudinal (T1)
magnetic resonance relaxation times are difficult to detect at con-
centrations below 10 mM, whereas most clinically or biologically
interesting target analytes are present at much lower levels, often
in the nanomolar or subnanomolar range. In part for this reason,422 Chemistry & Biology 21, 422–429, March 20, 2014 ª2014 Elseviethere has been considerable interest in exploring strategies for
amplifying the contrast arising from molecular species in MRI
(Hsieh and Jasanoff, 2012; Tu et al., 2011).
Enzymes are widely used to amplify molecular signals, both in
nature and in a broad array of biological assays. Prominent
examples of enzymatic strategies in conventional histology and
light microscopy include the use of b-galactosidase (b-gal)
(Goring et al., 1987), luciferase (DiLella et al., 1988), and other
proteins as reporter genes, and the application of horseradish
peroxidase (Nakane and Pierce, 1966) and alkaline phosphatase
(Avrameas, 1969) conjugates for immunodetection. Strategies
for detection of enzymes in MRI are less developed but actively
researched. One of the first instances of reporter enzyme detec-
tion in MRI used a gadolinium-based T1 contrast agent that
undergoes an increase in potency after cleavage by b-gal (Louie
et al., 2000); other MRI-detectable b-gal substrates have since
been introduced (Arena et al., 2011; Cui et al., 2010; Keliris
et al., 2011). Additional strategies for enzyme detection by MRI
have used molecular mechanisms that lead to local accumula-
tion of paramagnetic species such as iron ions, iron oxide nano-
particles, and gadolinium complexes (reviewed in Westmeyer
and Jasanoff, 2007). Although several proofs of concept have
been produced using these approaches in cell culture and live
organisms, few approaches have been applied in subsequent
studies, and there is a need for continued improvement and
innovation in this research area.
In recent work we presented a system for detecting activity of
a secreted enzymatic reporter in MRI (Westmeyer et al., 2010).
By harnessing an extracellular enzyme, the secreted alkaline
phosphatase (SEAP) (Berger et al., 1988), we obviated the
need for intracellular delivery of an MRI contrast agent, which
can be a substantial hurdle for in vivo imaging studies. We
detected an SEAP product by using an MRI contrast agent
sensor, rather than by using a contrast agent as a substrate itself.
Advantages of this strategy are that it is reversible upon product
removal and that the contrast agent is not used up. A disadvan-
tage is the complexity of the detection mechanism that requires
delivery both of an SEAP substrate and of a supramolecular iron
oxide-based MRI sensor to their sites of action. We therefore




















Figure 1. Schematic of the SEAP/Mn-TPPP4 Reporter Approach
SEAP (red) is produced by genetically modified cells and acts on the MRI
contrast agent Mn-TPPP4 (structure shown), cleaving up to four phosphates
and inducing precipitation of the products that have low solubility compared
with Mn-TPPP4. Accumulation of dephosphorylated contrast agents leads
to local increases in T1-weighted MRI contrast in the vicinity of cells
expressing SEAP.
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MRI Reporter Detection Using a Solubility SwitchSEAP activity by MRI in vivo. Paramagnetic manganese porphy-
rins are among the strongest contrast agents for T1-weighted
MRI (Chen et al., 1984; Koenig et al., 1987), and we showed in
another study (Lee et al., 2010) that labile zinc binding by an
anionic porphyrin-based molecular imaging agent (Zhang
et al., 2007) promotes localization of the probe in tissue,
probably because of a change in the charge of the complex.
We reasoned that an anionic phosphoporphyrin designed to be
a substrate for SEAP could undergo a phosphatase-catalyzed
solubility switch (Yao et al., 2007) and accumulate similarly in
the presence of SEAP reporter expression (Figure 1). Visualiza-
tion of the product would then occur after depletion of the solu-
ble starting material that would be expected to wash out within
several hours in vivo (Lee et al., 2010). The mechanism of
contrast induction in this scenario parallels approaches used
successfully to detect tumor-associated proteases in cancer
models (Lepage et al., 2007; Gringeri et al., 2012). Here we eval-
uate SEAP in combination with a solubility-switching porphyrin
substrate in vitro and in intact tissue, and we provide indication
of the potential utility of this strategy for reporter enzyme moni-
toring by MRI and optical histology.
RESULTS
Aphosphorylatedmetalloporphyrin, manganese(III)-tetraphenyl-
porphyrin phosphate (Mn-TPPP4), was synthesized and charac-
terized in vitro. The unmetallated version of this compound has
been shown previously to act as a substrate for tissue-nonspe-
cific alkaline phosphatase (Kawakami and Igarashi, 1995), and
the axial p-phosphophenyl groups of TPPP4 are structurally
similar to the promiscuous phosphatase substrate p-nitrophe-
nylphosphate (Hudson et al., 1947), known to be cleaved
by SEAP, and its membrane-anchored placental isoform
placental alkaline phosphatase (PLAP). Mn-TPPP4was therefore
expected be progressively dephosphorylated, via tri-, bis-, and
monophosphate intermediates, to manganese(III)-tetrahydroxy-Chemistry & Biology 21, 4phenylporphyrin (Mn-THPP), a compound containing four axial
p-hydroxyphenyl groups. Varying concentrations of Mn-TPPP4
(6–191 mM) in 100 ml volumes were incubated with 0.01 unit of
PLAP (10 pmol) from a commercial source and assayed opti-
cally and by MRI. In fact, Mn-TPPP4 underwent a sharp change
in solubility in the presence of PLAP, forming a dark green pre-
cipitate that could be removed from suspension by centrifuga-
tion (Figure 2A). Precipitation did not occur when a control
protein, BSA, was added in place of PLAP. The phosphatase-
dependent solubility change of the porphyrin agent was accom-
panied by a spectral change resulting in a shift of lmax from 469
to 476 nm (Figure 2B). The time course of enzymatic dephos-
phorylation was also followed via liquid chromatography-mass
spectrometry and showed increasing accumulation of partially
dephosphorylated product (m/z = 811 for Mn-TPPP monoester)
and completely dephosphorylated product (m/z = 731 for
Mn-THPP) over a 60 min period (Figure S2 available online).
The buildup of these species also corresponded inversely to
the time course of material remaining in solution over time, as
judged by optical absorbance of reaction mixture supernatants
sampled over the same period (correlation coefficients > 0.9,
p < 0.01).
MRI properties of a solution of Mn-TPPP4 also changed upon
addition of PLAP. Before addition of enzyme, Mn-TPPP4 modu-
lated the T1 relaxation rate (R1) according to its relaxivity
(r1, slope of R1 versus concentration) of 6.1 ± 0.07 mM
1s1.
The observed R1 was dramatically affected by addition of
PLAP, however, due primarily to enzyme-catalyzed precipita-
tion. When 0.01 unit of enzyme was added to a 127 mM solution
of Mn-TPPP4 and incubated for 30min, theR1 of themixture was
0.29 ± 0.01 s1. Incubation with an equivalent amount of BSA led
to a substantially larger R1 of 0.76 ± 0.05 s
1. Similar relaxation
differences were observed for lower concentrations of
Mn-TPPP4 (Figure 2C), and the linearity of R1 values versus
[Mn-TPPP4] in both PLAP- and BSA-supplemented conditions
indicated that observed R1 changes were due to the action of
the phosphatase, rather than to spontaneous precipitation of
the contrast agent. According to this analysis, the apparent r1
of the enzymatically dephosphorylated porphyrin species was
2.4 ± 0.1 mM1s1, a reduction by more than 50% compared
with r1 of the untreated substrate. We also compared apparent
relaxivity measurements in buffers at pH 4.5 designed to mimic
endocytic conditions, and we found no significant differences
from those recorded at pH 7 (see Experimental Procedures).
These results suggest that enzyme-catalyzed dephosphoryla-
tion of Mn-TPPP4 should also be detectable as T1 contrast
changes in MRI scans in cellular environments.
As an initial test of the Mn-TPPP4 solubility switch mechanism
in a biological context, we examined the effect of expressing
SEAP in cell culture on the behavior of Mn-TPPP4 in culture
supernatants. Human embryonic kidney 293 (HEK293) cells
were transfected with DNA constructs directing expression of
SEAP or enhanced yellow fluorescent protein (EYFP). After coin-
cubation of the cells with 13 mMMn-TPPP4 forR2.5 hr in media,
supernatant fractions were withdrawn and analyzed. As with the
addition of purified enzyme, SEAP secretion into culture medium
induced formation of a precipitate that could be pelleted by
centrifugation (Figure S1A). Formation of this precipitate also re-





Figure 2. Action of PLAP on Mn-TPPP4
(A) Solutions of Mn-TPPP4 ranging from 6 to
191 mM in factors of two were incubated with 0.01
unit of PLAP (bottom row) or an equivalent amount
of BSA (top row) in 100 ml microtiter wells,
centrifuged after 30 min, and photographed
in Eppendorf tubes. Concentration-dependent
buildup of precipitate is visible in the SEAP
condition but not the BSA condition.
(B) Action of PLAP on Mn-TPPP4 also induces a
shift in the absorbance spectrum of the porphyrin.
Here spectra were obtained from samples after incubation of 1 unit of SEAP or 1 nmol of BSA for 30 min with 70 mM Mn-TPPP4. AU, arbitrary units.
(C) Effect of varying concentrations of Mn-TPPP4 on the T1 relaxation rate of buffered saline solutions was assessed in the presence of 0.01 unit of SEAP or 10
pmol of BSA. The difference in R1 from background (DR1) is linear as a function of Mn-TPPP4 concentration and shows an expected decrease in the DR1 after
dephosphorylation and reduction in solubility of the contrast agent. Error bars denote SDs of the means of two independent measurements.
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observed changes were minor in the presence of cells express-
ing EYFP in place of SEAP suggests that Mn-TPPP4 turnover
should permit relatively specific detection of the SEAP reporter
in biologically complex environments.
SEAP/PLAP has been used previously as a marker in histolog-
ical studies of gene expression in the rodent central nervous
system (DePrimo et al., 1996; Fields-Berry et al., 1992). As a
proof-of-principle of the Mn-TPPP4 solubility switch mechanism
for gene expression mapping by MRI, we therefore investigated
whether the compound could detect SEAP expression in genet-
ically modified rat brain slices. Sprague-Dawley rats were
injected in the right and left thalamus with adeno-associated
serotype 9 (AAV9) viral vectors driving SEAP or control gene
(GFP) expression from constitutive cytomegalovirus (CMV) pro-
moters. Three to 6 weeks after infection, animals were sacrificed
and brains were removed and processed by standard tech-
niques used previously for histochemical analysis of SEAP
expression. Brain slices were subjected to uniform staining
withMn-TPPP4 and then visualized byMRI and light microscopy.
Ex vivo MRI was performed with a custom surface coil on a 9.4 T
scanner, using a 2D T1-weighted spin echo pulse sequence with
a 100 mm in-plane resolution and repetition and echo times (TR
and TE, respectively) equal to 100 and 12ms, respectively. Brain
slices adjacent to the slices used for MRI scanning were treated
with 5-bromo-4-chloro-3-indoylphosphate (BCIP) and nitro-blue
tetrazolium (NBT), a chromogenic combination of reagents that
forms a dark purple precipitate in the presence of alkaline phos-
phatase activity and that is conventionally used for visualization
of SEAP expression patterns.
Figure 3 shows representative MRI and optical results. A clear
T1-weighted hyperintensity is found near the coordinates of
AAV9-SEAP viral deposition in Figure 3A, whereas T1 enhance-
ment is not visible on the contralateral side where control virus
was delivered. Analysis of the raw signal intensities (Figure 3B)
shows that the MRI intensity on the hyperintense side is roughly
two times the signal level seen on the control side. Accumulation
of the contrast agent is also visible optically, because of the
strong absorbance of Mn-TPPP4 and its dephosphorylated
analogs. Figure 3C shows a light micrograph of the same brain
slice scanned for Figure 3A. The strong, dark green staining
visible on the right side is similar in color to the precipitates
visible in the in vitro experiments of Figure 2 and Figure S1 and
corresponds spatially to the hyperintensity detected by MRI.424 Chemistry & Biology 21, 422–429, March 20, 2014 ª2014 ElsevieThis indicates that the MRI contrast observed in this experiment
most likely arises directly from localized accumulation of the
dephosphorylated contrast agent near the injection site for the
SEAP-expressing viral vector, despite the fact that the entire
brain slice was exposed to Mn-TPPP4 before imaging. Evalua-
tion of SEAP expression profiles by the BCIP-NBT staining
method (Figure 3D) reveals a largely similar pattern of staining.
The correspondence of BCIP-NBT and MRI results further
supports the validity of the MRI-based SEAP imaging approach
and indicates that the MRI method resolves SEAP activity with
efficacy comparable to the established histological method.
To address the ability of theMn-TPPP4 solubility switchmech-
anism for detecting SEAP expression in vivo, we combined viral
injection with local delivery of the contrast agent by intracranial
injection into live rat brains. Approximately ten weeks after
stereotaxic injection of viruses encoding SEAP or GFP (control)
into thalamic targets, animals were anesthetized with isoflurane
and infused with 6 ml of 635 mM Mn-TPPP4 in artificial cerebro-
spinal fluid (aCSF). Within 2 hr of contrast agent injection,
animals were scanned using a cross coil radiofrequency appa-
ratus on a 4.7 T MRI scanner (fast low-angle shot pulse
sequence, 50/5 ms TR/TE, 250 mm isotropic resolution). Further
scan sessions were performed on subsequent days after
Mn-TPPP4 delivery. After the last imaging session, animals
were sacrificed and brain slices prepared for visualization by
optical absorbance and BCIP-NBT staining. Histological slices
showed no evidence of tissue toxicity in brain volumes filled
with porphyrin or associated with elevated BCIP-NBT reactivity.
MRI scans were analyzed, following earlier procedures from our
lab, by defining cylindrical regions of interest (ROIs) with a diam-
eter and length of 1.75mm near the contrast agent injection sites
and by evaluating mean signal intensity normalized by signal
intensity in control regions lateral to the test areas.
A sample image series is shown in Figure 4A. Bilateral signal
increases are apparent, but with greater MRI signal near the
injection site pretreated with AAV9-SEAP. Signal increases
observed on both SEAP-expressing and control sides decrease
over time after contrast agent delivery, with consistently higher
MRI signal remaining in the SEAP-expressing hemisphere
throughout the time course. These MRI enhancements were
consistent with postmortem examination of BCIP-NBT and
Mn-TPPP4 staining patterns (Figure 4B). Figure 4C shows group
data obtained from five AAV9-SEAP injection sites, three AAV9-
GFP control sites, and two vehicle control sites. Average MRIr Ltd All rights reserved
SEAP control































Figure 4. Mn-TPPP4 Induces Amplified Contrast in Areas of SEAP
Expression In Vivo
(A) MRI scans obtained over 3 days from an animal infected with AAV9-SEAP
(left) and AAV9-GFP (control, right) and treated with identical infusions of
Mn-TPPP4 at the injection sites. T1 contrast at the SEAP site is higher than the
control on day 0 (2 hr after contrast agent delivery) and persists with
diminishing amplitude over subsequent imaging sessions.
(B) The brain from (A) was perfused and sectioned after scanning. Sections
from near the injection sites were stained with BCIP-NBT to reveal phospha-
tase activity (top) and left unstained to reveal intrinsic porphyrin absorbance.
The control side (right) of the brain slice was marked with a notch.
(C) Group data from AAV9-SEAP (n = 5) and control injections of AAV9-GFP
(n = 3) or vehicle (n = 2) injection sites, showing persistently higher Mn-TPPP4
staining on the 3 days including and after the day of contrast agent delivery.
The degree of staining was statistically significant with respect to both controls









Figure 3. MRI Microscopy of SEAP Expression in an Mn-TPPP4-
Stained Brain Slice
(A) T1-weightedMRI scan of a 100-mm-thick brain slice from an animal infected
with AAV9 viral vectors encoding SEAP or GFP (control) injected into right and
left thalamus, respectively. The brain slice was notched (white arrowhead)
purposefully to mark the control side.
(B) A cross-section through the image (dotted line in [A]) indicates the relative
MRI signal across the slice; roughly 2-fold higher MRI signal is observed in
SEAP-expressing region. Scale bar, 2 mm.
(C) Light micrograph of the section imaged in (A), showing dark green staining
in the region of greatest contrast agent accumulation and MRI contrast.
(D) A neighboring brain slice stained with the BCIP-NBT method to map SEAP
by conventional histology shows a clear focus of heightened phosphatase
activity centered around the area of AAV9-SEAP infection and contrast agent
accumulation. Some likely nonspecific staining is also apparent (black
arrowhead).
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normalized by the mean signal in neighboring ROIs that did not
receive contrast agent injections. Approximately 2 hr after Mn-
TPPP4 injection, relative MRI signal in SEAP-expressing brain
regions was 41% ± 4% above baseline, whereas relative signal
in GFP expression regions was 19% ± 9% above baseline and
relative signal at vehicle control sites was 9% ± 9%; the
reporter-dependent difference was statistically significant with
t test p < 0.04 compared with each control. Two days after
contrast agent infusion, relative MRI signal in SEAP, GFP, and
vehicle sites was 21% ± 3%, 9% ± 5%, and 6% ± 7%, respec-
tively, reflecting weakening of the contrast difference over time.
The differences between contrast time courses observed after
Mn-TPPP4 injection in the absence versus presence of SEAP
expression could also bemimicked in untransduced rats by con-
trol injections of the fully dephosphorylated product Mn-THPP
(solubilized at pH 14) and of an uncleavable Mn-TPPP4 analog,
Mn(III)-meso-tetrakis(4-sulfonatophenyl)porphyrin (Mn-TPPS4),
in which the phosphates of Mn-TPPP4 are replaced by sulfonate
groups; this further validates the proposed mechanism for
contrast agent accumulation in the presence of SEAP (Figure S3).
The ability of Mn-THPP to induce T1 contrast enhancement,
despite its relative insolubility, was consistent with its in vitro
relaxivity of 0.82 ± 0.02 mM1s1, measured under conditions
of the intracerebral injection in aCSF (pH 14). As a test for the
influence of endogenous phosphatase activity on the observed
MRI contrast patterns, Mn-TPPP4 was injected in the absence
or presence of 5 mM sodium orthovanadate, a phosphatase
inhibitor with submicromolar inhibition constants for tissue-Chemistry & Biology 21, 4nonspecific alkaline phosphatases. No significant phosphatase
inhibitor-dependent contrast differences were observed (Fig-
ure S4). These experiments therefore collectively show that the
Mn-TPPP4 solubility switch mechanism permits specific detec-
tion of SEAP reporter expression in vivo. Although unbiased
spatial mapping of SEAP activity patterns across the entire brain
would require trans-blood-brain barrier (BBB) delivery of
Mn-TPPP4, the results presented here provide a foundation for
improvement and broader application of the technique in living
animals.
DISCUSSION
We describe a strategy for gene visualization by MRI, based on
reporter enzyme-catalyzed precipitation and accumulation of
an MRI contrast agent. This mechanism parallels successful
strategies for gene product visualization by histology, but it has
not previously been applied for reporter protein detection by
MRI. We showed that the secreted reporter enzyme SEAP
directs dephosphorylation of the water-soluble metalloporphyrin
Mn-TPPP4 that forms an insoluble green precipitate that is visible
in vitro and by MRI in both sectioned and live tissue. The
expected origin and specificity of the contrast changes are
supported by detailed biochemical characterization and by22–429, March 20, 2014 ª2014 Elsevier Ltd All rights reserved 425
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phosphatase inhibition. We did not examine subcellular localiza-
tion of the dephosphorylated Mn-TPPP4 conversion products in
tissue, but in a previous study of intracerebrally injected metallo-
porphyrin probes, a weakly cationic complex similar to THPP
was found to be predominantly cytosolic, as opposed to
partitioned into membranous or nuclear compartments (Lee
et al., 2010). In contrast, the relatively fast depletion ofMn-TPPP4
and its analog Mn-TPPS4 is consistent with a predominantly
extracellular distribution. Our data do not demonstrate whether
Mn-TPPP4 cleavage products bind to proteins, lipids, or other
hydrophobic components of the tissue, but it is possible that
such interactions contribute to the apparent relaxivity and
perhaps also to the retention of hydrophobic metalloporphyrins
in vivo.
Because of the optical activity of the dephosphorylated
Mn-TPPP4 products, we were able to compare MRI scans with
direct visualization of the accumulated metalloporphyrins in light
microscopy. We could also compare results with histological
staining for SEAP using the established BCIP-NBT method
(Stoker and Bissell, 1987). Excellent agreement was found in
ex vivo brain samples obtained from rats infected with targeted
infusion of viral vectors carrying the SEAP gene. Homogeneous
exposure to Mn-TPPP4 across entire brain samples led to
well-defined contrast enhancement only near areas expressing
SEAP, corresponding closely to BCIP-NBT results. In initial
in vivo experiments, intracranially injected Mn-TPPP4 also
stained SEAP-expressing brain areas more effectively than
control areas.
The MRI signal changes we reported in tests of the SEAP
reporter detection method approached 100% ex vivo (Figure 3)
and 40% in vivo (Figure 4). These differences were obtained
using strong viral expression of SEAP and delivery of substantial
amounts of substrate (0.5 mM Mn-TPPP4), but further appli-
cations of the method might involve lower levels of reporter
expression or substrate delivery. If necessary to boost signal,
repeated substrate infusions could be applied, making use of
the outstanding stability of SEAP/PLAP expression in vivo
(Wang et al., 2001). Further improvements to the reporter visual-
ization technique might also be accessible through protein engi-
neering of the enzyme or the design of altered substrates with
increased product relaxivity, better turnover, or greater speci-
ficity for SEAP. For experiments in living brains, an additional
obvious area for improvement will be the development of a strat-
egy for homogeneous trans-BBB delivery of SEAP substrates
(Lelyveld et al., 2010). Ultrasound (US)-mediated BBB disruption
has been shown to deliver MRI-detectable contrast agents to
rodent brains (Vykhodtseva et al., 2008), in some cases spatially
homogeneously (Howles et al., 2010), and it may be an ideal
technique for this purpose. Agents of widely varying sizes can
be delivered using US-mediated disruption, and porphyrin
agents similar to Mn-TPPP4 appear to be amenable to this tech-
nique as well (unpublished data). A second BBB disruption tech-
nique, mannitol-mediated hyperosmotic shock (Neuwelt and
Rapoport, 1984), has also been used for MRI contrast agent de-
livery, and it could be useful in the future. It should be noted that
for putative applications outside the brain, SEAP reporter imag-
ingwithMn-TPPP4might not require special delivery techniques.
A further area where the need for BBB permeability might be426 Chemistry & Biology 21, 422–429, March 20, 2014 ª2014 Elsevieavoided is in applications to ex vivo neuroimaging and MRI
microscopy. Ex vivo results in Figure 3 show quite strong and
enzyme-specific contrast by the standards of current magnetic
resonance-based gene imaging strategies, obviously facilitated
by the fact that SEAP substrate Mn-TPPP4 could be washed
homogeneously over all areas of the tissue and by the reduction
of background phosphatase activity due to histological pro-
cessing. Similar application of this Mn-TPPP4/SEAP staining
method in conjunction with other anatomical or analyte-sensitive
contrast techniques might have utility for understanding aspects
of tissue structure and function by MRI.
In an explicit comparison with previously introduced MRI-
based strategies for gene reporter imaging, the SEAP/Mn-
TPPP4 strategy may offer both strengths and weaknesses. Like
most other enzyme-based reporter strategies (Hsieh and Jasan-
off, 2012), themethod presented here requires a synthetic, exog-
enous substrate, an obvious disadvantage compared with MRI
gene reporters based on endogenous metal accumulation (Bar-
telle et al., 2012; Cohen et al., 2005; Genove et al., 2005).
Because the SEAP substrate is not a biological molecule, how-
ever, it is not subject to regulation by biological mechanisms,
and it may provide greater contrast. Compared with other MRI
enzyme reporter systems, detection of SEAP is facilitated by
the fact that the reporter enzyme is extracellular rather than cyto-
solic (Matsushita et al., 2012; Westmeyer et al., 2010). The fact
that contrast in the SEAP imaging method is due to probe accu-
mulation versus relaxivity changes may also present an advan-
tage (Olson et al., 2010; Weissleder et al., 2000). Only probes
modified by the reporter enzyme accumulate and induce
contrast enhancements, whereas unmodified probes wash
away within a day or so. Importantly, this avoids the need to
distinguish differences in probe concentration from differences
in relaxivity, a problem associated with many MRI reporter sys-
tems in which responsive enzymatic substrates are used.
Compared with chemical exchange saturation transfer (CEST)
agents designed to respond to enzymes (Airan et al., 2012; Li
et al., 2011; Liu et al., 2011; Yoo and Pagel, 2006), T1 contrast-
based systems have the disadvantage of being more difficult
to analyze quantitatively; determining the amount of probe accu-
mulation is not possible without knowledge of the background
T1, which in most cases would best be measured before
Mn-TPPP4 delivery. Conversely, the T1 contrast mechanism
probably offers greater signal-to-noise ratio, and the solubility
switch mechanism applied here could also be adapted to
promote accumulation of a CEST agent if desired.
A significant benefit of the SEAP/Mn-TPPP4 system for appli-
cations in animals is the possibility of combined MRI and optical
readouts from stained tissue (Lee et al., 2010). Here this is
achieved using a single paramagnetic chromophore platform,
so separation of moieties used for dual-modality imaging in
chemical conjugate contrast agents is not a potential problem.
This advantage is further complemented by the availability of
an additional MRI readout for SEAP activity (Westmeyer et al.,
2010), plus the possibility of using fluorescent and luminescent
substrates that couldmakemultimodal imaging with this enzyme
a tractable possibility (Berger et al., 1988). Transgenic reporter
mice expressing membrane-bound PLAP to label specific
neuronal subpopulations are also available (Badea et al., 2009)
and may provide improved spatial localization of multimodalr Ltd All rights reserved
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enzyme used in the present study. Although further work is
required to demonstrate robust in vivo imaging with SEAP,
both specific molecular aspects of the strategy introduced
here and the general approach of directing an MRI enzyme
reporter to catalyze probe accumulation via a solubility switch
could inspire further studies in living animals.
SIGNFICANCE
We have presented a novel approach to genetic reporter
imaging by MRI in which a synthetic water-soluble contrast
agent, Mn-TPPP4, undergoes cleavage and localized pre-
cipitation in the vicinity of an extracellular enzyme, SEAP.
The accumulation-based contrast mechanism has poten-
tially higher dynamic range than reporter imaging methods
based on relaxivity changes, and optical absorbance of the
porphyrin-based contrast agent enables direct comparison
of results obtained by MRI and histology. Robust ex vivo
reporter mapping was achieved using the SEAP/Mn-TPPP4
system in virally infected rat brain slices, and initial in vivo
experiments demonstrate that injected Mn-TPPP4 also
produces substantial T1-weighted MRI contrast enhance-
ments in areas where SEAP is expressed. Brain applications
of the SEAP/Mn-TPPP4 reporter imaging approach could
be extended in conjunction with trans-BBB delivery tech-
niques. The results demonstrate advantages of optically
active porphyrin-based MRI contrast agents for multimodal
molecular imaging. The more general idea of using an extra-
cellular transgene product to catalyze a switch in the solubi-
lity of a diffusible small molecule contrast agent may prove
valuable for future MRI-based reporter imaging incorpo-
rating SEAP or other enzymes.
EXPERIMENTAL PROCEDURES
Reagents and Supplies
Chemicals, including solubilized PLAP, were obtained from Sigma-Aldrich
unless otherwise noted. Mn-THPP, Mn-TPPS4, and Mn-TPPP4 were obtained
from Frontier Scientific. AAV9 viral vectors were prepared by Virovek.
Animal Subjects
Male Sprague-Dawley rats (250–300 g) were purchased from Charles River
Laboratories. After arrival, animals were housed and maintained on a 12 hr
light/dark cycle and permitted ad libitum access to food and water. All
procedures were performed in strict compliance with the Committee on
Animal Care guidelines of Massachusetts Institute of Technology.
Enzymatic Conversion of Mn-TPPP4
Different concentrations of Mn-TPPP4 (6–191 mM)were incubated at 37
Cwith
0.01 unit of SEAP or the equivalent amount of BSA (1 unit is defined as the
amount of enzyme that will hydrolyze 1 mmol of 4-nitrophenyl phosphate per
minute at pH 10.4 and 37C). Samples were subsequently spun down for
30 min at 20,000 3 g and photographed to document different amounts of
precipitate. Spectra were acquired on a SpectraMax M2 plate reader
(Molecular Devices), and data were exported into MATLAB (Mathworks) for
processing and plotting.
Liquid Chromatography-Mass Spectrometric Analysis
Mn-TPPP4 (0.5 mM) was incubated with PLAP (300 mU) at 37
C (50 mM Tris
and 1 mM MgCl2 [pH 9]), and the reaction was stopped with 10 ml of trifluoro-
acetic acid (TFA) at the time points indicated in Figure S2A. High-performanceChemistry & Biology 21, 4liquid chromatography (HPLC) separation was performed with a 1290 Infinity
HPLC system using an Eclipse C-18 analytical scale column (Agilent
Technologies) with gradients ranging from 30% to 100% acetonitrile with
0.1% TFA. Flow rate was 0.6 ml/min and injection volume was 2.5 ml. Mass
spectrometric evaluation was accomplished on a Citius high-resolution TOF
mass spectrometer from Leco. Electrospray ionization was performed in
positive ionization mode with a mass range from 100 to 2,000 atomic mass
units. Mass calibration was achieved by periodic coinfusion of the ESI-L low
concentration tuning mix from Agilent. Tuning compound mass accuracies
were in the range of 0.01–0.34 ppm and resolutions were between 30 and
60 (mass/full width at half peak height). Solvents for liquid chromatography-
mass spectrometric procedures were obtained from J. T. Baker.
Cell Culture Experiments
HEK293 cells were transiently transfected using Lipofectamine 2000 (Life
Technologies) with constructs coding for SEAP (pSEAP2-Control) from
Clontech. Two days after transfection, 13 mMMn-TPPP4 and 1mM orthovana-
date were added in reduced serum media (Opti-MEM) from Life Technologies
and incubated for 2.5 or 4.5 hr. Supernatants were subsequently arrayed into
multititer plates and analyzed by spectroscopy and MRI.
Intracranial Injections
To achieve thalamic expression of SEAP, Sprague-Dawley rats were
positioned in a stereotaxic frame, anesthetized with isoflurane, and implanted
bilaterally with MRI compatible 26G guide cannulae of 1.5 mm length (Plastics
One) that were stably fixated with dental cement. Injection cannulae (Plastics
One) were connected via silicon-oil-filled polyethylene tubing (PE-50) to a PhD
2000 syringe pump (Harvard Apparatus) and backfilled with solutions contain-
ing AAV9 viral particles at a titer of 7 3 1012 viral genomes (vg)/ml encoding
mouse SEAP (Wang et al., 2001) driven by a CMV promoter. Injection cannulae
were inserted into the guide cannulae and lowered to the thalamic target
region (2.5 mm lateral to midline, 6 mm below dura, 2.5 mm caudal to
bregma). A volume of 3 ml of viral particles was injected at 0.1 ml/min; then,
the cannulae were moved up twice by 2 mm to inject an additional 3 ml each
time. Control injection sites received AAV9 encoding CMV promoter-driven
GFP (1.5 3 1012 vg/ml) using an identical protocol. Injection cannulae were
subsequently retracted slowly and replaced with dummy cannulae (Plastics
One) that screwed firmly into the guide cannula pedestals. On the day of the
first in vivo imaging experiment shown in Figure 4, the dummy cannulae
were removed and an injection cannula was inserted that was backfilled
with the substrate (635 mM Mn-TPPP4) solutions, 3 ml of which was injected
into the same thalamic coordinate 6 mm below the dura, and another 3 ml at
4 mm below the dura. Injection cannulae were subsequently slowly retracted
and replaced with dummy cannulae that were permanently sealed with dental
cement. For the injection experiments shown in Figure S3, 4 ml of 0.5 mM
Mn-TPPS4 or Mn-THPP (solubilized at pH 14) in aCSF was injected
intracranially at 0.1 ml/min into the cortex (3.5 mm lateral to bregma, 2 mm
below dura). For injection experiments shown in Figure S4, 1.5 mMMn-TPPP4
was delivered with or without 5 mM sodium orthovanadate. In this experiment,
1 ml aliquots of each sample were applied at three depths (3.5, 3, and 2.5 mm
and below dura), all with a with a flow rate of 0.1 ml/min.
Histology
Animals were perfused with 4% paraformaldehyde, and the brains were
extracted and sliced in 100 mm sections on a vibratome to prepare for colori-
metric alkaline phosphatase assay. Sections were heated at 65C for 90min in
preheated PBS and incubated with BCIP-NBT. Sections were subsequently
washed briefly and mounted onto cover slides. Slides were scanned on a
photo scanner at 600 dots per inch. Image contrast was linearly adjusted in
Photoshop (Adobe Systems).
MRI
For in vitro measurements, samples were prepared as detailed above, arrayed
into microtiter plates, and placed in a 40 cm bore Avance 4.7 or 9.4 T MRI
scanner (Bruker). Unused wells were filled with buffer, and imaging was
performed on a 1 mm slice through the sample. A spin echo pulse sequence
with TR ranging from 63 ms to 8 s was used (TE was 8.5 ms; data matrices
of 128 3 128 points). Images were reconstructed, and R1 values were22–429, March 20, 2014 ª2014 Elsevier Ltd All rights reserved 427
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(Mathworks). Dependence of relaxivity on pH was examined by comparing
r1 and r2 values measured at 9.4 T and at pH 7 versus pH 4.5. No significant
differences were observed, with r1 = 6.1 mM
1s1 and r2 = 11 mM
1s1 at
both pH values. After incubation with 10 units of PLAP, apparent relaxivities
of r1 = 1.37 ± 0.01 and r2 = 21.5 ± 0.2 mM
1s1 were observed at pH 7;
corresponding values measured 1 hr after acidification to pH 4.5 were r1 =
1.34 ± 0.08 mM1s1 and r2 = 23 ± 1 mM
1s1, again indicating negligible
effect of pH.
For ex vivo experiments, animals were perfused, and then the brains were
extracted and cut on a vibratome to sections of 100 mm thickness. The
sections were then heated for 90 min at 65C in preheated PBS, followed by
overnight incubation with 500 mM Mn-TPPP4 in 100 mM Tris (pH 9.5). After
staining, slices were washed with PBS and embedded in mounting media.
Embedded sections were scanned on a 9.4 T scanner (Bruker), using a
T1-weighted 2D spin echo pulse sequence with 100 mm in-plane resolution
(TR/TE = 100/12 ms). For in vivo experiments, animals were anesthetized
with isoflurane, prepared for intracranial injections as described above, and
positioned on a heated animal bed in a 4.7 T MRI scanner (Bruker). Fast
low-angle shot images with TR/TE = 50/5 ms and 250 mm isotropic resolution
were acquired 2 hr after Mn-TPPP4 injection and then on subsequent days.
Data for Figure S3 were acquired with a fast spin echo sequence with an
acceleration factor of 4, TR/TE = 510/13 ms, and 210 mm in-plane resolution.
MRI images were reconstructed using custom routines in MATLAB. Coronal
MRI slices from subsequent imaging days of each animal were spatially
registered to the first imaging day using routines implemented in MATLAB
(Medical Image Registration Toolbox; Myronenko and Song, 2010). ROI
analysis for Figure 4 and Figure S4 was performed by positioning cylindrical
ROIs over the bilateral injection sites (diameter of 1.5 mm and length of
1.75 mm, centered on the cannulae tips) and computing relative signal ampli-
tudes, normalized by average signal in nearby control ROIs,3.5 mm lateral to
injection sites, that did not receive substrate. ROIs for Figure S4 were ellipses
centered on the cannulae tips with 1.7 mm diameter in the coronal plane and
0.84 mm diameter along the rostrocaudal axis.SUPPLEMENTAL INFORMATION
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